Celcuity
CELC----
Celcuity (CELC)
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Celcuity Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
$163.5497.94%
Forecast & RatingStrong buy
12analysts
- Strong buy83.33%
- Buy16.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 15 hours ago
FDA Approvals and Earnings Beats Propel Specialized US-Listed Firms
- Global Report · 1 day ago, 04:14 AM
The 'Everything Else' Trade: 10 Outliers Defining the 2026 Market
- Global Report · Jul 21 at 04:13 AM
The Value Chain Dictates the Outcome: From Defense Platforms to Biotech Aggregators
- Simplywall · Jul 18 at 08:05 PM
3 US Growth Stocks Analysts Expect To Benefit From AI Infrastructure Demand
- rttnews · Jul 18 at 12:22 AM
Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data
- Tip Ranks · Jul 17 at 08:05 AM
Celcuity (CELC) Receives a Buy from Leerink Partners
